An Assessment of Adherence of Patients to Anti-Hypertensive Medication and Factors for Non-Adherence in Oromia Region Adama Referral Hospital, Ethiopia

Belayneh Kefale; Abate Wondesen

Authors

Belayneh Kefale
Abate Wondesen

Keywords:

hypertensive patients, adherence, adama, prescribed medication

Abstract

Background: Hypertension (HTN), or high blood pressure (systolic blood pressure >140 mmHg and diastolic blood pressure >90 mmHg) is an overwhelming global challenge which ranks third as a cause of disability-adjusted life-year. Hypertension causes 7.1 million premature deaths each year worldwide and accounts for 13% of all deaths globally. There are effective medical therapies for hypertension management; but the problem of non-adherence to medical treatment remains a challenge for the medical professionals and social scientists. The objective of this study is to assess the magnitude of adherence and factors for non adherence related to anti-hypertensive treatments in hypertensive patients visiting Adama Referral Hospital.

Downloads

How to Cite

An Assessment of Adherence of Patients to Anti-Hypertensive Medication and Factors for Non-Adherence in Oromia Region Adama Referral Hospital, Ethiopia. (2015). Global Journal of Medical Research, 15(10), 29-36. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

Author Biographies

Belayneh Kefale

Belayneh Kefale holds a B.Pharm from Wollo University and an MSc from Addis Ababa University. Currently, he is pursuing his PhD at the University of Tasmania, focusing on optimizing anticoagulant therapy in hospitalized patients, particularly those with atrial fibrillation. With extensive experience in clinical pharmacy research, he has served as a clinical preceptor and lecturer at leading higher education institutions in Ethiopia. His research spans a wide range of areas, including therapeutic drug optimization and monitoring, pharmaceutical care, medication safety, and the therapeutic outcomes of non-communicable diseases (NCDs). He is also deeply engaged in addressing challenges related to antimicrobial resistance, infectious diseases, and pharmacoeconomics. Belayneh is passionate about bridging the gap between clinical research and real-world patient care, contributing to evidence-based pharmaceutical practices. His work has led to significant insights into optimizing drug therapy, enhancing patient safety, and improving healthcare outcomes. He has authored over 50 research articles and has made substantial contributions to advancing clinical pharmacy and healthcare policy.

Abate Wondesen

Belayneh Kefale Gelaw is affiliated with Ambo University, College of Medicine and Health Science, Department of Pharmacy, located in Ambo, Ethiopia. He holds a B.pharm qualification and has authored multiple research papers focused on medical research, treatments, HIV/AIDS research, infectious diseases, and surgery. He has served as a reviewer and author for medical journals.

References

D. Greeff (2006) An approach to preventing and treating hypertension through Lifestyle modification. 10(5), 8-22.

D. Sackett (1976) The magnitude of compliance and noncompliance. 9-25.

Main Contreras EM, etal (1995) Observancia terapeutica enla hipertension arterial. 16(8), 496-500.

Myers ED, Branthwaite A (1992) Out-patient compliance with antidepressant medications. 160, 83-86.

Abula T (2000) Patient noncompliance with therapeutic regimens and the factors of noncompliance in Gondar. 14(1), 1-6. https://doi.org/10.4314/ejhd.v14i1.9924

L. Benet (1996) Principles of prescription order writing and patient compliance instructions. 1697-1706.

S. Griffith (1990) A review of the factors associated with patient compliance and the taking of prescribed medicines. 40, 114-116.

BM Psaty, T. Lumley, CD Furberg, G. Schellenbaum, M. Pahor, MH Alderman, NS Weiss (2003) Health outcomes associated with various antihypertensive therapies used as first-line agents: a networkmetaanalysis. 289, 2534.

G. Thrall, G. Lip, D. Lane (2004) Compliance with pharmacological therapy in hypertension: can we do better, and how?. 18(9), 595-597. https://doi.org/10.1038/sj.jhh.1001722